Munshi, Medha
Slyne, Christine
Weinger, Katie
Sy, Sarah
Sifre, Kayla
Michals, Amy
Davis, Dai’Quann
Dewar, Rachel
Atakov-Castillo, Astrid
Haque, Saira
Cummings, M. Stirling
Brown, Stephen L.
Toschi, Elena
Funding for this research was provided by:
NIH DP3 (1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01, 1DP3DK112214-01)
Diabetes Research Center (2P30DK036836, 2P30DK036836, 2P30DK036836, 2P30DK036836, 2P30DK036836, 2P30DK036836, 2P30DK036836, 2P30DK036836)
Article History
Received: 18 January 2023
Accepted: 18 April 2023
First Online: 29 April 2023
Competing interests
: MNM: Consultant for Sanofi. CS: No conflicts of interest relevant to this article were reported. KW: No conflicts of interest relevant to this article were reported. SS: No conflicts of interest relevant to this article were reported. KS: No conflicts of interest relevant to this article were reported. AM: No conflicts of interest relevant to this article were reported. DD: No conflicts of interest relevant to this article were reported. RD: No conflicts of interest relevant to this article were reported. AAC: No conflicts of interest relevant to this article were reported. SH: Current employee and shareholder at Pfizer. SC: No conflicts of interest relevant to this article were reported. SLB: No conflicts of interest relevant to this article were reported. ET: Consultant for Medtronic.